Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S MacMahon

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|June 27, 1992
Cholesterol and total mortality: need for larger trialsR Collins, A Keech, R Peto, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health OrganizationJ Chalmers, S MacMahon, G Mancia, et al.
Blood Pressure|June 1, 1993
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meetingA Zanchetti, J P Chalmers, K Arakawa, et al.
Stroke|September 6, 2003
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trialM Fransen, C Anderson, J Chalmers, et al.
Journal of Nephrology|January 1, 1997
Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative GroupR Robson, J Collins, R Johnson, et al.
BMJ (Clinical Research Ed.)|October 5, 2013
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials, T Ninomiya, V Perkovic, et al.
Circulation|February 17, 1999
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.
Journal of the American College of Cardiology|June 13, 2001
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.
Neurology|February 8, 2008
APOE genotype, ethnicity, and the risk of cerebral hemorrhageC Tzourio, H Arima, S Harrap, et al.
Cardiovascular Drugs and Therapy|October 4, 2022
The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS TrialsS P Radhoe, E Boersma, M Bertrand, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|June 27, 1992
Cholesterol and total mortality: need for larger trialsR Collins, A Keech, R Peto, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health OrganizationJ Chalmers, S MacMahon, G Mancia, et al.
Blood Pressure|June 1, 1993
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meetingA Zanchetti, J P Chalmers, K Arakawa, et al.
Stroke|September 6, 2003
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trialM Fransen, C Anderson, J Chalmers, et al.
Journal of Nephrology|January 1, 1997
Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative GroupR Robson, J Collins, R Johnson, et al.
BMJ (Clinical Research Ed.)|October 5, 2013
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials, T Ninomiya, V Perkovic, et al.
Circulation|February 17, 1999
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.
Journal of the American College of Cardiology|June 13, 2001
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.
Neurology|February 8, 2008
APOE genotype, ethnicity, and the risk of cerebral hemorrhageC Tzourio, H Arima, S Harrap, et al.
Cardiovascular Drugs and Therapy|October 4, 2022
The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS TrialsS P Radhoe, E Boersma, M Bertrand, et al.
Pageof 14